You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API LAMIVUDINE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing LAMIVUDINE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
GlaxoSmithKline LLC EPIVIR lamivudine 0173-0662 CELLULOSE, MICROCRYSTALLINE
GlaxoSmithKline LLC EPIVIR lamivudine 0173-0662 FERRIC OXIDE RED
GlaxoSmithKline LLC EPIVIR lamivudine 0173-0662 FERRIC OXIDE YELLOW
GlaxoSmithKline LLC EPIVIR lamivudine 0173-0662 HYPROMELLOSE
GlaxoSmithKline LLC EPIVIR lamivudine 0173-0662 MAGNESIUM STEARATE
GlaxoSmithKline LLC EPIVIR lamivudine 0173-0662 POLYETHYLENE GLYCOL
GlaxoSmithKline LLC EPIVIR lamivudine 0173-0662 POLYSORBATE 80
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing LAMIVUDINE

Company Ingredient NDC Excipient
Major Pharmaceuticals lamivudine 0904-6583 ANHYDROUS LACTOSE
Major Pharmaceuticals lamivudine 0904-6583 CROSPOVIDONE
Major Pharmaceuticals lamivudine 0904-6583 HYDROXYPROPYL CELLULOSE
Major Pharmaceuticals lamivudine 0904-6583 HYPROMELLOSE
Major Pharmaceuticals lamivudine 0904-6583 MAGNESIUM STEARATE
Major Pharmaceuticals lamivudine 0904-6583 POLYETHYLENE GLYCOL
Major Pharmaceuticals lamivudine 0904-6583 SILICON DIOXIDE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for LAMIVUDINE

Excipient focus: ALCOHOL

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BANANA

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: EDETATE DISODIUM

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: ISOMALT

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: METHYLENE CHLORIDE

Excipient focus: METHYLPARABEN

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: POWDERED CELLULOSE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

LAMIVUDINE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Company Ingredient NDC
GlaxoSmithKline LLC lamivudine 0173-0662
Rebel Distributors Corp lamivudine 21695-367
Camber Pharmaceuticals Inc lamivudine 31722-001
Macleods Pharmaceuticals Limited lamivudine 33342-001
ViiV Healthcare Company lamivudine 49702-203
Ingenus Pharmaceuticals LLC lamivudine 50742-623
ECI Pharmaceuticals LLC lamivudine 51293-832
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SODIUM STARCH GLYCOLATE TYPE B POTATO

Excipient focus: STARCH, CORN

Excipient focus: STRAWBERRY

Excipient focus: SUCROSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group